None (CSBRD) Price, Holdings, & News

ETF Overview

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• Assets Under Management: $291.24 million
• Dividend Yield: N/A
• Net Expense Ratio: 0.00%
• Aggregate Rating: N/A

CSBRD ETF - Frequently Asked Questions

How do I buy shares of None?

Shares of CSBRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Fund Details

• Fund Name: None
• Stock Exchange: NYSEARCA
• Current Symbol: NYSEARCA:CSBRD
• Inception Date: 1/1/2100
• Fund Manager: N/A
• Web: N/A
• Phone: (410) 369-0365

Fund Focus

• Benchmark: N/A
• Number of Holdings: 0

Fund Statistics

• Assets Under Management: $291.24 million
• Average Daily Volume: $0.00
• Discount/Premium: 0.00%

Administrator, Advisor and Custodian

• Administrator: N/A
• Advisor: N/A
• Custodian: N/A
• Distributor: N/A
• Transfer Agent: N/A
• Trustee: N/A
• Lead Market Maker: N/A

Miscellaneous

• Outstanding Shares: N/A
• Beta: N/A